Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Main exclusion criteria included BMI 20 kg/m2, type 1 diabetes, type 2 diabetes, if previously treated with insulin or with oral hypoglycemic or insulin-sensitizing agents, history of malignancy, and hypopituitarism
Never dispose of medicines in household waste or down the drain
A 2022 systematic review and meta-analysis published in JAMA Internal Medicine found that GLP-1 receptor agonists as a class were associated with increased biliary disease risk
The two primary forms used are sodium stibogluconate (SSG) and meglumine antimoniate (MA), each administered as parenteral drugs (IM, IV, or IL) at a standard dose of 20 mg/kg/day for 2830 days (Pokharel et al., 2021)
Reduces dark spots, sunspots, and acne scars
